DaVita announced new research center at the St. Anthony Central Hospital
January 2012 FOCUS Newsletter
Unveiling of the new TerumoBCT flag and exterior signage
CaridianBCT and Terumo Transfusion are becoming Terumo BCT, the world leader in blood component technology.
Ventria Bioscience - Denver Post
Pueblo, Fort Collins lead economic comeback in Colorado
The Denver Post
VC-backed startups now free to chase SBIR grant money
Denver Business Journal
by Greg Avery, Reporter
Clarimedix, Inc. Secures Investment for Proof-of-Concept Study in Cerebral Vasospasm
MBio Diagnostics, Inc. Announces CEO, Chris Myatt to present at Biotech Showcase
Boulder, CO, January 10, 2012 – MBio Diagnostics, Inc. announced that its CEO, Christopher
Myatt, Ph.D., will present at the BioTech Showcase 2012 in San Francisco on January 11th at
9:00 a.m PST at San Francisco’s Parc 55 Wyndham hotel. Dr. Myatt will present an overview on
the Company including its accomplishments in 2011 and its focus for 2012 and the future.
MBio Diagnostics, Inc. (www.mbiodx.com) is a privately held clinical diagnostics and life
sciences technology company based in Boulder, CO. MBio is developing a suite of simple,
multiplexed diagnostic tests using its proprietary LightDeckTM technology. Initial product
development focuses on high impact infectious diseases, including HIV, hepatitis, and influenza.
The company’s product development is aimed at decentralized testing, from the clinic to the
St. Renatus Secures $3.5 Million to Proceed With Phase 3 Trials
FORT COLLINS, Colo., Jan. 9, 2012 St. Renatus, LLC, the northern Colorado start-up company founded to commercialize and distribute a new needle-free dental anesthetic, announced today that the company secured up to $3.5 million dollars from an angel investment group, and will move forward with Phase 3 clinical trials.
Biodesix Receives New EU and US Patents for Blood-based Oncology Tests
Gov. Hickenlooper announces regulatory reform and red tape reduction for state government
DENVER — Monday, Jan. 9, 2012 — Gov. John Hickenlooper today unveiled recommendations to reduce government “red tape” and regulatory inefficiencies based on feedback from more than 100 business organizations, local governments, advocacy and community groups statewide.